Atopic Dermatitis, Eczema, Eczema-Prone Skin
Conditions
Brief summary
This is a single-arm, open-label, decentralized (fully remote) clinical trial evaluating the tolerability and self-perceived skin effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in 35 adults aged 18-65 with self-reported eczema-prone skin. Participants will use the body wash once daily in place of their usual cleanser, followed by the Skin Recovery Cream, for 4 consecutive weeks.
Interventions
DIETARY_SUPPLEMENTRejuvaskin Eczema Body Wash
Participants use Rejuvaskin Eczema Body Wash once daily during a shower or bath in place of their usual body cleanser, followed by application of Rejuvaskin Skin Recovery Cream, for 4 consecutive weeks.
Sponsors
Rejuvaskin
Citruslabs
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Adult women or men aged 18-65 years. * Self-reported symptoms of eczema or eczema-prone skin (e.g., dryness, roughness, itching, irritation on the body). * Visible signs of eczema such as dryness, roughness, or irritation on at least one part of the body at the time of enrollment. * Willing to use Rejuvaskin Eczema Body Wash once daily as their primary body cleanser for 4 consecutive weeks. * Willing to use Rejuvaskin Skin Recovery Cream once daily after using the - Rejuvaskin body cleanser for 4 consecutive weeks. * Willing to maintain their current diet, skincare routine (aside from substitution of body wash and skin cream), and lifestyle habits for the study duration. * Willing and able to take standardized photographs of an affected body area at Baseline and Week 4 using a personal smartphone. * Able to read, understand, and complete questionnaires in English. * Resides in the United States with a valid shipping address. * Willing to provide informed consent and comply with all study procedures
Exclusion criteria
* Known allergy or sensitivity to any ingredient in the study product. * Currently pregnant, breastfeeding, or planning to become pregnant during the study period. * Active, severe skin condition on the body requiring prescription topical or systemic treatment (e.g., active severe atopic dermatitis flare under medical care, active infection at intended application sites). * Currently using prescription topical corticosteroids, calcineurin inhibitors, or other prescription topical eczema treatments on the body, or initiation of such treatment planned during the study. * Currently participating in another clinical or skincare research study, or planning to enroll during this study's duration. (
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline in Self-Reported Skin Dryness | Baseline to Week 4 | Mean change in self-reported dryness measured via a structured self-report questionnaire administered through the Citruslabs platform |
| Change from Baseline in Self-Reported Skin Roughness | Baseline to Week 4 | Mean change in self-reported roughness measured via a structured self-report questionnaire administered through the Citruslabs platform |
| Change from Baseline in Self-Reported Skin Itch | Baseline to Week 4 | Mean change in self-reported itch measured via a structured self-report questionnaire administered through the Citruslabs platform |
| Change from Baseline in Self-Reported Skin Irritation | Baseline to Week 4 | Mean change in self-reported irritation measured via a structured self-report questionnaire administered through the Citruslabs platform |
| Change from Baseline in Self-Reported Skin Discomfort | Baseline to Week 4 | Mean change in self-reported discomfort measured via a structured self-report questionnaire administered through the Citruslabs platform |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline in Self-Reported Skin Hydration | Baseline to Week 4 | Mean change in self-reported skin hydration measured via a 0-10 Numeric Rating Scale (NRS) self-report questionnaire |
| Change from Baseline in Self-Reported Skin Comfort | Baseline to Week 4 | Mean change in self-reported skin hydration measured via a 0-10 Numeric Rating Scale (NRS) self-report questionnaire |
| Expert Dermatologist-Graded Change in Erythema | Baseline and Week 4 | Independent expert dermatologist grading of change in erythema from standardized photographs of a designated affected body area |
| Expert Dermatologist-Graded Change in Scaling | Baseline and Week 4 | Independent expert dermatologist grading of change in scaling from standardized photographs of a designated affected body area |
Countries
United States
Outcome results
None listed